Cell Production and GMP Rooms

Developed by: IBIMA. Instituto de Investigación Biomédica de Málaga


 These are facilities that meet specific parameters for manufacturing based on stem cells for therapeutic purposes and which are subject to strict safety requirements verified by the Spanish Agency for Medicines and Health Products (AEMPS), the entity responsible for providing final accreditation  for operation. Manufacturing operations authorized by AEMPS, to date, are isolation and expansion of mesenchymal stem cells derived from adipose tissue.


three GMP rooms where clinical trials are carried out with cell therapy medicinal products. 

Both the infrastructure and the team that supports the CPU, foster different lines of R&D in Cell Therapy and cater to the different medical-surgical disciplines of the Andalusian Public Health Service (SSPA) hospitals and other partner institutions wishing to implement Cell Therapy and Regenerative Medicine as treatment.